A network for analyzing kidney biopsy data in glomerular diseases
Official title: Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research
Run by Seoul National University Hospital · NCT03929887 · Data updated 2026-11-12
This study is trying to build a detailed database of kidney biopsy samples and health information from patients with glomerular diseases to help researchers better understand these conditions and improve treatments.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 6 sites (Chuncheon and 5 other locations) |
| Status | Recruiting |
| Started | May 1, 2019 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | February 12, 2020 |
| Trial ID | NCT03929887 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients suspected of glomerular disease who are undergoing kidney biopsy at participating medical centers.
✕Probably not a fit
Patients who have previously received a kidney transplant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a comprehensive database of kidney biopsy samples and associated clinical data for patients with glomerular diseases such as Minimal Change Disease and IgA Nephropathy. By leveraging advances in molecular analysis and bioinformatics, the study seeks to enhance understanding of the biology of glomerulonephritis and improve precision medicine approaches in nephrology. The Korean Kidney Biopsy Network (KORNERSTONE) will collect long-term observational data and genomic information from kidney tissues, which will be archived in a web-based platform for easy access by researchers.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment options for patients with glomerular diseases.
How similar studies have gone: Other studies utilizing genomic data from kidney biopsies have shown promise in advancing understanding and treatment of kidney diseases, suggesting this approach is both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Inclusion criteria * Patient suspected of glomerular disease who received kidney biopsy in participating university medical centers * Children (age\<18 years) also included 2. Exclusion criteria - Patients who previously received a kidney transplant
Where it's running
-
KangWon National University Hospital
Chuncheon, South Korea Recruiting -
Keimyung University Dongsan Medical Center
Daegu, South Korea Recruiting -
Chung-Ang University Hosptial
Seoul, South Korea Recruiting -
Seoul National University Hospital
Seoul, South Korea Recruiting -
Severance Hospital
Seoul, South Korea Recruiting -
SMG-SNU Boramae Medical Center
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Yong Chul Kim, MD,PhD.
- Email: imyongkim@gmail.com
- Phone: +82-10-8874-7429
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing ManNAc for treating kidney disease FSGS
This study is testing if a new oral treatment called ManNAc can help adults with kidney disease FSGS by reducing protein levels in their urine and checking how safe it is over 12 weeks.
-
National Registry for Rare Kidney Diseases
This study is collecting health information from people with rare kidney diseases to help improve treatments and create better care guidelines.
-
Exploring experiences of patients and parents dealing with swelling from Nephrotic Syndrome
This study talks to patients and parents about their experiences with swelling from Nephrotic Syndrome to help create better ways to measure how new treatments work.
-
NEPTUNE Match: Personalized matching of patients to kidney treatment options
This project will try a system that matches people in the NEPTUNE cohort who have nephrotic syndromes or related kidney diseases with suitable clinical trials and shares those matches with patients and their doctors.
-
Observational study on kidney transplant recurrence in FSGS and MCD
This study is looking at patients with kidney diseases called FSGS and MCD who have had or will have a kidney transplant to see how often these diseases come back afterward.
-
Vagus nerve stimulation for treating nephrotic syndrome in children
This study is testing whether a new treatment using vagus nerve stimulation can help children aged 3 to 17 with nephrotic syndrome feel better and reduce their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.